Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: October 30, 2026 at 4:09 AM UTC
| NCT Number | NCT07686263 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | PHASE3 |
| Target Enrollment | 472 participants |
| Active Locations | 34 sites in the US |
| Sponsor | Karuna Therapeutics, Inc., a Bristol Myers Squibb company |
| Last Updated on CT.gov | September 28, 2026 (Sep 28, 2026) |
As of October 30, 2026: Clinical trial NCT07686263 is currently recruiting participants. This phase3 study for schizophrenia is actively seeking new participants at 34 locations across the United States. The study is sponsored by Karuna Therapeutics, Inc., a Bristol Myers Squibb company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07686263 is actively recruiting participants as of October 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 34 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07686263 was last updated Sep 28, 2026 (September 28, 2026). HelloStudys verifies this status automatically.